Analysts Set Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) Price Target at $11.00

Shares of Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six analysts that are currently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 […]

Leave a Reply

Your email address will not be published.

Previous post Adyen N.V. Unsponsored ADR (OTCMKTS:ADYEY) Receives Consensus Recommendation of “Buy” from Analysts
Next post InterRent REIT (TSE:IIP) Receives Consensus Rating of “Reduce” from Brokerages